Ad
related to: monocyte marker gene editing function
Search results
Results from the WOW.Com Content Network
CCL2 is primarily secreted by monocytes, macrophages and dendritic cells. Platelet derived growth factor is a major inducer of CCL2 gene. CCR2 and CCR4 are two cell surface receptors that bind CCL2. [14] CCL2 exhibits a chemotactic activity for monocytes and basophils. However, it does not attract neutrophils or eosinophils.
CXCL10 is secreted by several cell types in response to IFN-γ.These cell types include monocytes, endothelial cells and fibroblasts. [5] CXCL10 has been attributed to several roles, such as chemoattraction for monocytes/macrophages, T cells, NK cells, and dendritic cells, promotion of T cell adhesion to endothelial cells, antitumor activity, and inhibition of bone marrow colony formation and ...
Said et al. showed that activated monocytes express high levels of PD-1 which might explain the higher expression of PD-1 in CD14 + CD16 ++ monocytes as compared to CD14 ++ CD16 − monocytes. Triggering monocytes-expressed PD-1 by its ligand PD-L1 induces IL-10 production, which activates CD4 Th2 cells and inhibits CD4 Th1 cell function. [ 23 ]
6355 n/a Ensembl ENSG00000108700 n/a UniProt P80075 n/a RefSeq (mRNA) NM_005623 n/a RefSeq (protein) NP_005614 n/a Location (UCSC) Chr 17: 34.32 – 34.32 Mb n/a PubMed search n/a Wikidata View/Edit Human Chemokine (C-C motif) ligand 8 (CCL8), also known as monocyte chemoattractant protein 2 (MCP2), is a protein that in humans is encoded by the CCL8 gene. CCL8 is a small cytokine belonging to ...
Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly insert genetic material into a host genome, genome editing targets the insertions to site-specific locations.
CCR2 surface expression on blood monocytes changes in a time-of-day–dependent manner (being higher at the beginning of the active phase) and affects monocytes recruitment in tissues including the heart. As a consequence when an acute ischemic event happens during the active phase, monocytes are more susceptible to invade the heart. [10]
The gene then needs to be mapped by comparing the inheritance of the phenotype with known genetic markers. Genes that are close together are likely to be inherited together. [12] Another option is reverse genetics. This approach involves targeting a specific gene with a mutation and then observing what phenotype develops. [12]
In July 2018, the ECJ ruled that gene editing for plants was a sub-category of GMO foods and therefore that the CRISPR technique would henceforth be regulated in the European Union by their rules and regulations for GMOs. [37] In February 2020, a US trial showed safe CRISPR gene editing on three cancer patients. [38]
Ad
related to: monocyte marker gene editing function